An EU consortium to identify novel targets and drugs for cancer treatment

Cancer is one of the leading causes of death in Europe and worldwide. Although significant advances have been made in cancer research, it still remains a public health concern with a survival rate of about 50%. It is therefore of great importance to develop new and specific drug treatments for cancer. The EU collaborative project CancerPathways combines scientific expertise of eight partners to produce fundamental advances in our understanding of cancer biology and how this disease can be attacked. read more >